Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01131091 · ClinicalTrials.gov registry record · Phase 1
A Multicenter, Open Label, Single Dose Study to Evaluate the Effect of Renal Insufficiency on the Pharmacokinetics of SK 0403
A Phase 1 study, sponsored by Kowa Research Institute.
- Completed
- Registry status
- Phase 1
- Development phase
- 30
- Enrollment target
NCT01131091 is a Phase 1 study that has completed, run by Kowa Research Institute. The registered enrollment target is 30 participants.
The verdict
NCT01131091, a Phase 1 study, has completed, sponsored by Kowa Research Institute.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 30 participants
- Enrollment target
Study Summary
This is a Phase 1, multicenter, open label, single dose study. A total of 30 subjects are planned (5 groups of 6 subjects each.)
Interventions
- DRUG SK-0403
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2010-05 |
| Est. Completion | 2010-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01131091
The ClinicalTrials.gov registry entry for NCT01131091 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kowa Research Institute, which has 44 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which SK-0403 is the first listed.
NCT01131091 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01131091 about?
NCT01131091 is a clinical study titled "A Multicenter, Open Label, Single Dose Study to Evaluate the Effect of Renal Insufficiency on the Pharmacokinetics of SK 0403". This is a Phase 1, multicenter, open label, single dose study. A total of 30 subjects are planned (5 groups of 6 subjects each.)
What is the current status of trial NCT01131091?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2010-05. Estimated completion is 2010-11.
What interventions are being tested in trial NCT01131091?
The interventions under investigation include: SK-0403 (DRUG).
Who is sponsoring clinical trial NCT01131091?
This trial is sponsored by Kowa Research Institute, which has 44 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.